The first indication will be for severe diarrhea associated with chemotherapies for colorectal cancer. Current therapies include loperamide or octreotide. However, these drugs have limitation in alleviating severe late on-set diarrhea. Results from animal studies indicate that PHY906 administered concomitantly with chemotherapy agents does not impair or decrease the therapeutic index of the agents. Currently, there are no pharmaceutical treatments for AICH patients.
Current therapies are limited to surgical intervention and palliative treatments.
Results from preliminary human case studies show improved mortality rate as well as neurological function recovery if the drug is administered within 24 hour. Other herbal formulations are also being investigated at various stage of development. Copyright 2001 CompanyLongName All rights reserved. Send mail to CompanyEmail with questions or comments about this web site.